3DPrint.com | Additive Manufacturing Business
·
Fri, 03 Apr 2026 13:00:53 +0000
Canada Backs Aspect Biosystems With $280M to Scale Bioprinted Tissue Therapies
#3D printing
#additive manufacturing
• The Government of Canada is supporting bioprinting company Aspect Biosystems with a new $280 million project to help develop and manufacture its bioengineered cellular medicines. The project will run over...
Read original on 3DPrint.com | Additive Manufacturing Business
Related Stories
3DPrint.com | Additive Manufacturing Business
·
Fri, 03 Ap
Leading Chemical Manufacturer Kureha Makes Strategic Investment in Z-Polymers’ Advanced 3D Printing Materials
3DPrint.com | Additive Manufacturing Business
·
Fri, 03 Ap
Loughborough University Using Freemelt’s EBM Technology to Drive AM Research
3DPrint.com | Additive Manufacturing Business
·
Fri, 03 Ap
Divergent & GA-ASI: How Connecting at AMUG Led to an Important Industry Partnership
Make: DIY Projects and Ideas for Makers
·
Thu, 02 Ap